Literature DB >> 17389469

Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population.

Angayarkanni Narayanasamy1, Barathi Subramaniam, Coral Karunakaran, Punitham Ranganathan, Ramakrishnan Sivaramakrishnan, Tarun Sharma, Vasanthi Sengamedu Badrinath, Joseph Roy.   

Abstract

PURPOSE: The underlying cause of disturbed homocysteine metabolism is incompletely understood in young persons with central retinal vein occlusion (CRVO) with mild hyperhomocysteinemia (HHcys) and no other systemic disease in India. A 2-year prospective study was undertaken to determine whether HHcys is a risk factor for CRVO in an Indian population.
METHOD: The prevalence of fasting HHcys was evaluated in a consecutive series of 29 patients with CRVO (mean age, 30 +/- 6 years) along with 57 age- and sex-matched control subjects (healthy subjects, mean age 27 +/- 5 years). Strict inclusion and exclusion criteria were used. Plasma levels of homocysteine (Hcys), methionine, cysteine, glutathione, B(12), and folate were measured. Multivariate logistic regression analysis was performed to determine the risk factors for CRVO. RESULT: Fifteen of 29 patients with CRVO (51.72%) exhibited HHcys (>15 muM). The mean Hcys level was significantly elevated in the patients with CRVO (19.1 +/- 13.1 muM) compared with that in the healthy control subjects (14.7 +/- 6.2 muM) with P = 0.04. The increased Hcys levels in CRVO cases was associated with decreased methionine (P = 0.052) and decreased B(12) (P = 0.001). A multivariate logistic regression analysis revealed an odds ratio of 1.9 (95% CI = 0.50-7.16) for Hcys and 15.9 for methionine (95%CI = 1.50-169.62; P = 0.022).
CONCLUSION: Elevated Hcys and low methionine were risk factors for CRVO in an Indian population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389469     DOI: 10.1167/iovs.06-0905

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  To Study the Role of Serum Homocysteine Levels and Ocular Involvement in Retinal Vasculitis.

Authors:  Angad Miskin; Raji Kurumkattil; Anurodh Gupta; Hemant Singh Trehan; Puja Dudeja; Sanjay Kumar Dhar; Vijay Kumar Sharma
Journal:  Indian J Clin Biochem       Date:  2021-04-20

2.  A longitudinal analysis of risk factors associated with central retinal vein occlusion.

Authors:  Maxwell S Stem; Nidhi Talwar; Grant M Comer; Joshua D Stein
Journal:  Ophthalmology       Date:  2012-11-20       Impact factor: 12.079

3.  Presumed bilateral branch retinal vein occlusions secondary to antiepileptic agents.

Authors:  Rumana N Hussain; Somnath Banerjee
Journal:  Clin Ophthalmol       Date:  2011-05-13

4.  Retinal arterial occlusions in the young: systemic associations in Indian population.

Authors:  Dhanashree Ratra; Maneesh Dhupper
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

Review 5.  Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis.

Authors:  Dan Li; Minwen Zhou; Xiaoyan Peng; Huiyu Sun
Journal:  BMC Ophthalmol       Date:  2014-11-27       Impact factor: 2.209

6.  Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion.

Authors:  Shiu-Chen Wu; Yung-Sung Lee; Wei-Chi Wu; Shirley H L Chang
Journal:  BMC Ophthalmol       Date:  2016-05-31       Impact factor: 2.209

7.  Role of hyperhomocysteinemia and Vitamin B12 deficiency in central and hemi-central retinal vein occlusion: A case-control study.

Authors:  Dhipak Arthur; Deepa John; Jude Joseph Fleming; Grace Rebekah; Mahasampath Gowri; Sheeja Susan John
Journal:  Oman J Ophthalmol       Date:  2022-03-02

8.  Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study.

Authors:  Michael K Smolek; Neil F Notaroberto; Arley G Jaramillo; Lisa R Pradillo
Journal:  Clin Ophthalmol       Date:  2013-07-16

9.  Multiple extra macular branch retinal vein occlusions in hyperhomocysteinemia.

Authors:  Abhijit Diwakar Gore; Girish Shiva Rao; Mansi Abhijit Gore; Abhishek R Desai
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.